Browsing Tag
MagSense
1 post
Imagion Biosystems (ASX: IBX) soars 84% after FDA feedback on HER2 breast cancer trial
Imagion Biosystems surged 84% on FDA feedback for its breast cancer imaging trial. Find out what this means for its MagSense tech and investor outlook.